BioAtla Statistics

Total Valuation

BioAtla has a market cap or net worth of $136.89 million. The enterprise value is $58.18 million.

Market Cap	136.89M
Enterprise Value	58.18M

Important Dates

The last earnings date was Tuesday, May 14, 2024, after market close.

Earnings Date	May 14, 2024
Ex-Dividend Date	n/a

Share Statistics

BioAtla has 48.12 million shares outstanding. The number of shares has increased by 1.07% in one year.

Shares Outstanding	48.12M
Shares Change (YoY)	+1.07%
Shares Change (QoQ)	+0.21%
Owned by Insiders (%)	10.62%
Owned by Institutions (%)	61.14%
Float	35.64M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.75
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.49, with a Debt / Equity ratio of 0.04.

Current Ratio	4.49
Quick Ratio	n/a
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -140.40% and return on invested capital (ROIC) is -242.47%.

Return on Equity (ROE)	-140.40%
Return on Assets (ROA)	-88.30%
Return on Capital (ROIC)	-242.47%
Revenue Per Employee	n/a
Profits Per Employee	-$1.83M
Employee Count	65
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -19.37% in the last 52 weeks. The beta is 1.21, so BioAtla's price volatility has been higher than the market average.

Beta (1Y)	1.21
52-Week Price Change	-19.37%
50-Day Moving Average	2.86
200-Day Moving Average	2.31
Relative Strength Index (RSI)	49.48
Average Volume (30 Days)	644,116

Short Selling Information

The latest short interest is 5.33 million, so 11.08% of the outstanding shares have been sold short.

Short Interest	5.33M
Short Previous Month	5.42M
Short % of Shares Out	11.08%
Short % of Float	14.95%
Short Ratio (days to cover)	8.04

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-125.21M
Pretax Income	-119.24M
Net Income	-119.24M
EBITDA	-118.07M
EBIT	-119.24M
Earnings Per Share (EPS)	-$2.49

Full Income Statement

Balance Sheet

The company has $80.63 million in cash and $1.92 million in debt, giving a net cash position of $78.71 million or $1.64 per share.

Cash & Cash Equivalents	80.63M
Total Debt	1.92M
Net Cash	78.71M
Net Cash Per Share	$1.64
Equity / Book Value	49.72M
Book Value Per Share	1.03
Working Capital	67.17M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$112.19 million and capital expenditures -$48,000, giving a free cash flow of -$112.24 million.

Operating Cash Flow	-112.19M
Capital Expenditures	-48,000
Free Cash Flow	-112.24M
FCF Per Share	-$2.33

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BioAtla does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.07%
Shareholder Yield	-1.07%
Earnings Yield	-87.10%
FCF Yield	-81.99%

Analyst Forecast

The average price target for BioAtla is $14.50, which is 412.37% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$14.50
Price Target Difference	412.37%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-21.90%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2